Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Revenue: 2022-2025

Historic Revenue for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to $99.2 million.

  • Arcutis Biotherapeutics' Revenue rose 121.69% to $99.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $317.9 million, marking a year-over-year increase of 129.21%. This contributed to the annual value of $196.5 million for FY2024, which is 229.74% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Revenue of $99.2 million as of Q3 2025, which was up 21.74% from $81.5 million recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Revenue peaked at $99.2 million during Q3 2025, and registered a low of -$2.0 million during Q2 2022.
  • Its 3-year average for Revenue is $45.0 million, with a median of $44.8 million in 2024.
  • Data for Arcutis Biotherapeutics' Revenue shows a peak YoY skyrocketed of 4,037.93% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Arcutis Biotherapeutics' Revenue stood at $3.0 million in 2022, then spiked by 356.81% to $13.5 million in 2023, then surged by 427.58% to $71.4 million in 2024, then spiked by 121.69% to $99.2 million in 2025.
  • Its Revenue was $99.2 million in Q3 2025, compared to $81.5 million in Q2 2025 and $65.8 million in Q1 2025.